Veru Inc Ret. sur les actifs
Quel est le Ret. sur les actifs de Veru Inc?
Le Ret. sur les actifs de Veru Inc est -59.89%
Quelle est la définition de Ret. sur les actifs?
Le rendement des actifs indique dans quelle mesure les actifs d'une entreprise génèrent des revenus. Il est calculé en divisant le résultat net par l'actif total moyen.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. sur les actifs des entreprises dans Health Care secteur sur NASDAQ par rapport à Veru Inc
Que fait Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Entreprises avec ret. sur les actifs similaire à Veru Inc
- 01 Communique Laboratory a Ret. sur les actifs de -60.03%
- Titan Medical a Ret. sur les actifs de -59.98%
- RYU Apparel a Ret. sur les actifs de -59.96%
- Dyne Therapeutics a Ret. sur les actifs de -59.96%
- Mount Ridley Mines a Ret. sur les actifs de -59.93%
- SQZ Biotechnologies Co a Ret. sur les actifs de -59.91%
- Veru Inc a Ret. sur les actifs de -59.89%
- LSL Property Services Plc a Ret. sur les actifs de -59.88%
- iCo Therapeutics a Ret. sur les actifs de -59.87%
- Northern Minerals a Ret. sur les actifs de -59.86%
- Eyecarrot Innovations a Ret. sur les actifs de -59.82%
- SVM UK Emerging Fund Plc a Ret. sur les actifs de -59.81%
- Triangle (Global) a Ret. sur les actifs de -59.81%